Royalty Pharma PLC

NASDAQ:RPRX

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RPRX's stock price target?

Price Target

46.41 USD

According to Wall Street analysts, the average 1-year price target for RPRX is 46.41 USD with a low forecast of 37.37 USD and a high forecast of 63 USD.

What is Royalty Pharma PLC's Revenue forecast?

Projected CAGR

11%

For the last 5 years the compound annual growth rate for Royalty Pharma PLC's revenue is 6%. The projected CAGR for the next 3 years is 11%.

What is Royalty Pharma PLC's Operating Income forecast?

Projected CAGR

18%

For the last 5 years the compound annual growth rate for Royalty Pharma PLC's operating income is 2%. The projected CAGR for the next 3 years is 18%.

What is Royalty Pharma PLC's Net Income forecast?

Projected CAGR

34%

For the last 5 years the compound annual growth rate for Royalty Pharma PLC's net income is -4%. The projected CAGR for the next 3 years is 34%.